Поиск по каталогу |
(строгое соответствие)
|
- Профессиональная
- Научно-популярная
- Художественная
- Публицистика
- Детская
- Искусство
- Хобби, семья, дом
- Спорт
- Путеводители
- Блокноты, тетради, открытки
Chemopreventive potential of adrenergic blocker. Using prostate cancer induced rats
В наличии
Местонахождение: Алматы | Состояние экземпляра: новый |
Бумажная
версия
версия
Автор: Prakash Nargatti,Sudhir Patil and Nilofar Naikwade
ISBN: 9786202555050
Год издания: 2020
Формат книги: 60×90/16 (145×215 мм)
Количество страниц: 116
Издательство: LAP LAMBERT Academic Publishing
Цена: 32457 тг
Положить в корзину
Способы доставки в город Алматы * комплектация (срок до отгрузки) не более 2 рабочих дней |
Самовывоз из города Алматы (пункты самовывоза партнёра CDEK) |
Курьерская доставка CDEK из города Москва |
Доставка Почтой России из города Москва |
Аннотация: Psychosocial stress increasingly recognized as an important health issue in development and progression of cancer.Prostate cancer patients have increased levels of stress and anxiety. Several studies suggest that environmental factors are important in prostate cancer development. Patients with prostate cancer reportedly show higher levels of anxiety compared with other cancer patients. Based on psychoneuroimmunology we report that stress promotes prostate cancer in rats through stress response system. The sympathetic nervous system potentially regulate tumour ? and ?-adrenergic signalling both via circulating adrenaline/nor-adrenaline and via local nor-adrenaline release from SNS nerve fibres. Activation of the sympathetic nervous system promotes cancer progression via ?-adrenoreceptor–mediated activation of protein kinase A and exchange protein activated by adenylyl cyclase signalling pathways.Stimulation of ?¬ receptor leads to the activation of Ca++ permeable nonselective cationic channels and transient receptor potential (TRP) channel family, which are responsible for cell proliferation, which leads to prostate cancer progression.
Ключевые слова: Stress, Cancer, signalling pathway, kinase A, TRP channel family.